Abstract
The study of the pathogenesis of invasive pulmonary aspergillosis has advanced significantly over recent years because of scientific achievements on two fronts: sequencing of the genomes of three Aspergillus species and elucidation of the innate immune mechanisms involved in defence against Aspergillus infection. The principal events that lead to invasive aspergillosis take place in the alveolus, where inhaled conidia germinate into invading hyphae that penetrate the respiratory epithelium. Pulmonary innate immunity against Aspergillus infection consists of resident and recruited phagocytes, soluble immune factors, and antimicrobial proteins. Various Aspergillus traits, including the production of pigment, antioxidants, proteases, adhesins, siderophores, and mycotoxins, are implicated as potential virulence factors. The complex interplay amongst these factors, usually in the setting of depressed immunity, forms the basis for this medically important opportunistic mycosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Latge, J. P. (2001) The pathobiology of Aspergillus fumigatus. Trends Microbiol, 9, 382–9.
Marr, K. A., Patterson, T. & Denning, D. (2002) Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am, 16, 875–94, vi.
Morgan, J., Wannemuehler, K. A., Marr, K. A., Hadley, S., Kontoyiannis, D. P., Walsh, T. J., Fridkin, S. K., Pappas, P. G. & Warnock, D. W. (2005) Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol, 43(Suppl 1), S49–58.
Upton, A., Kirby, K. A., Carpenter, P., Boeckh, M. & Marr, K. A. (2007) Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis, 44, 531–40.
Nierman, W. C., Pain, A., Anderson, M. J., Wortman, J. R., Kim, H. S., Arroyo, J., Berriman, M., Abe, K., Archer, D. B., Bermejo, C., et al. (2005) Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature, 438, 1151–6.
Galagan, J. E., Calvo, S. E., Cuomo, C., Ma, L. J., Wortman, J. R., Batzoglou, S., Lee, S. I., Basturkmen, M., Spevak, C. C., Clutterbuck, J., Kapitonov, V. et al. (2005) Sequencing of Aspergillus nidulans and comparative analysis with A. fumigatus and A. oryzae. Nature, 438, 1105–15.
Machida, M., Asai, K., Sano, M., Tanaka, T., Kumagai, T., Terai, G., Kusumoto, K., Arima, T., Akita, O., Kashiwagi, Y. et al. (2005) Genome sequencing and analysis of Aspergillus oryzae. Nature, 438, 1157–61.
Bart-Delabesse, E., Humbert, J. F., Delabesse, E. & Bretagne, S. (1998) Microsatellite markers for typing Aspergillus fumigatus isolates. J Clin Microbiol, 36, 2413–8.
Ben-Ami, R., Lamaris, G., Lewis, R. & Kontoyiannis, D. (2008) Strain-to-strain variation in the virulence of Aspergillus isolates assessed in Toll deficient flies. In 3rd Advances Against Aspergillosis. Miami, USA.
Chazalet, V., Debeaupuis, J. P., Sarfati, J., Lortholary, J., Ribaud, P., Shah, P., Cornet, M., Vu Thien, H., Gluckman, E., Brucker, G. & Latge, J. P. (1998) Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings. J Clin Microbiol, 36, 1494–500.
Debeaupuis, J. P., Sarfati, J., Chazalet, V. & Latge, J. P. (1997) Genetic diversity among clinical and environmental isolates of Aspergillus fumigatus. Infect Immun, 65, 3080–5.
Brookman, J. L. & Denning, D. W. (2000) Molecular genetics in Aspergillus fumigatus. Curr Opin Microbiol, 3, 468–74.
Berg, C. M. & Garber, E. D. (1962) A genetic analysis of color mutants of Aspergillus fumigatus. Genetics, 47, 1139–46.
O’gorman, C. M., Fuller, H. T. & Dyer, P. S. (2008) Discovery of a sexual cycle in the opportunistic fungal pathogen Aspergillus fumigatus. Nature, 457, 471–4.
Falkow, S. (1988) Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis, 10(Suppl 2), S274–6.
Krappmann, S. (2006) Tools to study molecular mechanisms of Aspergillus pathogenicity. Trends Microbiol, 14, 356–64.
Bodey, G. P. & Vartivarian, S. (1989) Aspergillosis. Eur J Clin Microbiol Infect Dis, 8, 413–37.
Marr, K. A., Carter, R. A., Crippa, F., Wald, A. & Corey, L. (2002) Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis, 34, 909–17.
Hedayati, M. T., Pasqualotto, A. C., Warn, P. A., Bowyer, P. & Denning, D. W. (2007) Aspergillus flavus: human pathogen, allergen and mycotoxin producer. Microbiology, 153, 1677–92.
Augustowska, M. & Dutkiewicz, J. (2006) Variability of airborne microflora in a hospital ward within a period of one year. Ann Agric Environ Med, 13, 99–106.
Leenders, A. C., Van Belkum, A., Behrendt, M., Luijendijk, A. & Verbrugh, H. A. (1999) Density and molecular epidemiology of Aspergillus in air and relationship to outbreaks of Aspergillus infection. J Clin Microbiol, 37, 1752–7.
Hospenthal, D. R., Kwon-Chung, K. J. & Bennett, J. E. (1998) Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol, 36, 165–8.
Panagopoulou, P., Filioti, J., Petrikkos, G., Giakouppi, P., Anatoliotaki, M., Farmaki, E., Kanta, A., Apostolakou, H., Avlami, A., Samonis, G. & Roilides, E. (2002) Environmental surveillance of filamentous fungi in three tertiary care hospitals in Greece. J Hosp Infect, 52, 185–91.
Schmitt, H. J., Blevins, A., Sobeck, K. & Armstrong, D. (1990) Aspergillus species from hospital air and from patients. Mycoses, 33, 539–41.
Xavier, M. O., Sales Mda, P., Camargo Jde, J., Pasqualotto, A. C. & Severo, L. C. (2008) Aspergillus niger causing tracheobronchitis and invasive pulmonary aspergillosis in a lung transplant recipient: case report. Rev Soc Bras Med Trop, 41, 200–1.
Osherov, N. & May, G. S. (2001) The molecular mechanisms of conidial germination. FEMS Microbiol Lett, 199, 153–60.
Hope, W. W., Kruhlak, M. J., Lyman, C. A., Petraitiene, R., Petraitis, V., Francesconi, A., Kasai, M., Mickiene, D., Sein, T., Peter, J., Kelaher, A. M., Hughes, J. E., Cotton, M. P., Cotten, C. J., Bacher, J., Tripathi, S., Bermudez, L., Maugel, T. K., Zerfas, P. M., Wingard, J. R., Drusano, G. L. & Walsh, T. J. (2007) Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. J Infect Dis, 195, 455–66.
Weindl, G., Naglik, J. R., Kaesler, S., Biedermann, T., Hube, B., Korting, H. C. & Schaller, M. (2007) Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J Clin Invest, 117, 3664–72.
Agerberth, B., Grunewald, J., Castanos-Velez, E., Olsson, B., Jornvall, H., Wigzell, H., Eklund, A. & Gudmundsson, G. H. (1999) Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am J Respir Crit Care Med, 160, 283–90.
Schnapp, D. & Harris, A. (1998) Antibacterial peptides in bronchoalveolar lavage fluid. Am J Respir Cell Mol Biol, 19, 352–6.
Travis, S. M., Conway, B. A., Zabner, J., Smith, J. J., Anderson, N. N., Singh, P. K., Greenberg, E. P. & Welsh, M. J. (1999) Activity of abundant antimicrobials of the human airway. Am J Respir Cell Mol Biol, 20, 872–9.
Zarember, K. A., Sugui, J. A., Chang, Y. C., Kwon-Chung, K. J. & Gallin, J. I. (2007) Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus conidial growth by lactoferrin-mediated iron depletion. J Immunol, 178, 6367–73.
Wright, J. R. (2005) Immunoregulatory functions of surfactant proteins. Nat Rev Immunol, 5, 58–68.
Madan, T., Eggleton, P., Kishore, U., Strong, P., Aggrawal, S. S., Sarma, P. U. & Reid, K. B. (1997) Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun, 65, 3171–9.
Madan, T., Kishore, U., Singh, M., Strong, P., Hussain, E. M., Reid, K. B. & Sarma, P. U. (2001) Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis. Infect Immun, 69, 2728–31.
Bulpa, P., Dive, A. & Sibille, Y. (2007) Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J, 30, 782–800.
Filler, S. G. & Sheppard, D. C. (2006) Fungal invasion of normally non-phagocytic host cells. PLoS Pathog, 2, e129.
Paris, S., Boisvieux-Ulrich, E., Crestani, B., Houcine, O., Taramelli, D., Lombardi, L. & Latge, J. P. (1997) Internalization of Aspergillus fumigatus conidia by epithelial and endothelial cells. Infect Immun, 65, 1510–4.
Wasylnka, J. A. & Moore, M. M. (2003) Aspergillus fumigatus conidia survive and germinate in acidic organelles of A549 epithelial cells. J Cell Sci, 116, 1579–87.
Berkova, N., Lair-Fulleringer, S., Femenia, F., Huet, D., Wagner, M. C., Gorna, K., Tournier, F., Ibrahim-Granet, O., Guillot, J., Chermette, R., Boireau, P. & Latge, J. P. (2006) Aspergillus fumigatus conidia inhibit tumour necrosis factor- or staurosporine-induced apoptosis in epithelial cells. Int Immunol, 18, 139–50.
Amitani, R. (2008) Interaction of Aspergillus with human respiratory mucosa. In 3rd Advances Against Aspergillosis (AAA). Miami, USA.
Amitani, R., Murayama, T., Nawada, R., Lee, W. J., Niimi, A., Suzuki, K., Tanaka, E. & Kuze, F. (1995) Aspergillus culture filtrates and sputum sols from patients with pulmonary aspergillosis cause damage to human respiratory ciliated epithelium in vitro. Eur Respir J, 8, 1681–7.
Amitani, R., Taylor, G., Elezis, E. N., Llewellyn-Jones, C., Mitchell, J., Kuze, F., Cole, P. J. & Wilson, R. (1995) Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect Immun, 63, 3266–71.
Tomee, J. F., Wierenga, A. T., Hiemstra, P. S. & Kauffman, H. K. (1997) Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis, 176, 300–3.
Khoufache, K., Puel, O., Loiseau, N., Delaforge, M., Rivollet, D., Coste, A., Cordonnier, C., Escudier, E., Botterel, F. & Bretagne, S. (2007) Verruculogen associated with Aspergillus fumigatus hyphae and conidia modifies the electrophysiological properties of human nasal epithelial cells. BMC Microbiol, 7, 5.
Cordonnier, C., Gilain, L., Ricolfi, F., Deforges, L., Girard-Pipau, F., Poron, F., Millepied, M. C. & Escudier, E. (1996) Acquired ciliary abnormalities of nasal mucosa in marrow recipients. Bone Marrow Transplant, 17, 611–6.
Annaix, V., Bouchara, J. P., Larcher, G., Chabasse, D. & Tronchin, G. (1992) Specific binding of human fibrinogen fragment D to Aspergillus fumigatus conidia. Infect Immun, 60, 1747–55.
Bouchara, J. P., Bouali, A., Tronchin, G., Robert, R., Chabasse, D. & Senet, J. M. (1988) Binding of fibrinogen to the pathogenic Aspergillus species. J Med Vet Mycol, 26, 327–34.
Gil, M. L., Penalver, M. C., Lopez-Ribot, J. L., O'connor, J. E. & Martinez, J. P. (1996) Binding of extracellular matrix proteins to Aspergillus fumigatus conidia. Infect Immun, 64, 5239–47.
Beever, R. E. & Dempsey, G. P. (1978) Function of rodlets on the surface of fungal spores. Nature, 272, 608–10.
Thau, N., Monod, M., Crestani, B., Rolland, C., Tronchin, G., Latge, J. P. & Paris, S. (1994) rodletless mutants of Aspergillus fumigatus. Infect Immun, 62, 4380–8.
Banerjee, B., Greenberger, P. A., Fink, J. N. & Kurup, V. P. (1998) Immunological characterization of Asp f2, a major allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis. Infect Immun, 66, 5175–82.
Sentandreu, M., Elorza, M. V., Sentandreu, R. & Fonzi, W. A. (1998) Cloning and characterization of PRA1, a gene encoding a novel pH-regulated antigen of Candida albicans. J Bacteriol, 180, 282–9.
Warwas, M. L., Watson, J. N., Bennet, A. J. & Moore, M. M. (2007) Structure and role of sialic acids on the surface of Aspergillus fumigatus conidiospores. Glycobiology, 17, 401–10.
Wasylnka, J. A., Simmer, M. I. & Moore, M. M. (2001) Differences in sialic acid density in pathogenic and non-pathogenic Aspergillus species. Microbiology, 147, 869–77.
Philippe, B., Ibrahim-Granet, O., Prevost, M. C., Gougerot-Pocidalo, M. A., Sanchez Perez, M., Van Der Meeren, A. & Latge, J. P. (2003) Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun, 71, 3034–42.
Bonnett, C. R., Cornish, E. J., Harmsen, A. G. & Burritt, J. B. (2006) Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia. Infect Immun, 74, 6528–39.
Levitz, S. M., Selsted, M. E., Ganz, T., Lehrer, R. I. & Diamond, R. D. (1986) In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J Infect Dis, 154, 483–9.
Romani, L. (2004) Immunity to fungal infections. Nat Rev Immunol, 4, 1–23.
Brown, G. D. & Gordon, S. (2001) Immune recognition. A new receptor for beta-glucans. Nature, 413, 36–7.
Hohl, T. M., Van Epps, H. L., Rivera, A., Morgan, L. A., Chen, P. L., Feldmesser, M. & Pamer, E. G. (2005) Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog, 1, e30.
Luther, K., Torosantucci, A., Brakhage, A. A., Heesemann, J. & Ebel, F. (2007) Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the dectin-1 beta-glucan receptor and Toll-like receptor 2. Cell Microbiol, 9, 368–81.
Bellocchio, S., Montagnoli, C., Bozza, S., Gaziano, R., Rossi, G., Mambula, S. S., Vecchi, A., Mantovani, A., Levitz, S. M. & Romani, L. (2004) The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol, 172, 3059–69.
Balloy, V., Si-Tahar, M., Takeuchi, O., Philippe, B., Nahori, M. A., Tanguy, M., Huerre, M., Akira, S., Latge, J. P. & Chignard, M. (2005) Involvement of toll-like receptor 2 in experimental invasive pulmonary aspergillosis. Infect Immun, 73, 5420–5.
Levitz, S. M. (2004) Interactions of Toll-like receptors with fungi. Microbes Infect, 6, 1351–5.
Mambula, S. S., Sau, K., Henneke, P., Golenbock, D. T. & Levitz, S. M. (2002) Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem, 277, 39320–6.
Meier, A., Kirschning, C. J., Nikolaus, T., Wagner, H., Heesemann, J. & Ebel, F. (2003) Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol, 5, 561–70.
Netea, M. G., Ferwerda, G., Van Der Graaf, C. A., Van Der Meer, J. W. & Kullberg, B. J. (2006) Recognition of fungal pathogens by toll-like receptors. Curr Pharm Des, 12, 4195–201.
Wang, J. E., Warris, A., Ellingsen, E. A., Jorgensen, P. F., Flo, T. H., Espevik, T., Solberg, R., Verweij, P. E. & Aasen, A. O. (2001) Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae. Infect Immun, 69, 2402–6.
Netea, M. G., Warris, A., Van Der Meer, J. W., Fenton, M. J., Verver-Janssen, T. J., Jacobs, L. E., Andresen, T., Verweij, P. E. & Kullberg, B. J. (2003) Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis, 188, 320–6.
Bellocchio, S., Moretti, S., Perruccio, K., Fallarino, F., Bozza, S., Montagnoli, C., Mosci, P., Lipford, G. B., Pitzurra, L. & Romani, L. (2004) TLRs govern neutrophil activity in aspergillosis. J Immunol, 173, 7406–15.
Garlanda, C., Hirsch, E., Bozza, S., Salustri, A., De Acetis, M., Nota, R., Maccagno, A., Riva, F., Bottazzi, B., Peri, G., Doni, A., Vago, L., Botto, M., De Santis, R., Carminati, P., Siracusa, G., Altruda, F., Vecchi, A., Romani, L. & Mantovani, A. (2002) Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature, 420, 182–6.
Persat, F., Noirey, N., Diana, J., Gariazzo, M. J., Schmitt, D., Picot, S. & Vincent, C. (2003) Binding of live conidia of Aspergillus fumigatus activates in vitro-generated human Langerhans cells via a lectin of galactomannan specificity. Clin Exp Immunol, 133, 370–7.
Serrano-Gomez, D., Dominguez-Soto, A., Ancochea, J., Jimenez-Heffernan, J. A., Leal, J. A. & Corbi, A. L. (2004) Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin mediates binding and internalization of Aspergillus fumigatus conidia by dendritic cells and macrophages. J Immunol, 173, 5635–43.
Paris, S., Debeaupuis, J. P., Crameri, R., Carey, M., Charles, F., Prevost, M. C., Schmitt, C., Philippe, B. & Latge, J. P. (2003) Conidial hydrophobins of Aspergillus fumigatus. Appl Environ Microbiol, 69, 1581–8.
Tronchin, G., Bouchara, J. P., Ferron, M., Larcher, G. & Chabasse, D. (1995) Cell surface properties of Aspergillus fumigatus conidia: correlation between adherence, agglutination, and rearrangements of the cell wall. Can J Microbiol, 41, 714–21.
Gersuk, G. M., Underhill, D. M., Zhu, L. & Marr, K. A. (2006) Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. J Immunol, 176, 3717–24.
Steele, C., Rapaka, R. R., Metz, A., Pop, S. M., Williams, D. L., Gordon, S., Kolls, J. K. & Brown, G. D. (2005) The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog, 1, e42.
Wheeler, R. T. & Fink, G. R. (2006) A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog, 2, e35.
Hohl, T. M., Feldmesser, M., Perlin, D. S. & Pamer, E. G. (2008) Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure. J Infect Dis, 198, 176–85.
Lamaris, G. A., Lewis, R. E., Chamilos, G., May, G. S., Safdar, A., Walsh, T. J., Raad, I. I. & Kontoyiannis, D. P. (2008) Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. J Infect Dis, 198, 186–92.
Lopes Bezerra, L. M. & Filler, S. G. (2004) Interactions of Aspergillus fumigatus with endothelial cells: internalization, injury, and stimulation of tissue factor activity. Blood, 103, 2143–9.
Kamai, Y., Chiang, L. Y., Lopes Bezerra, L. M., Doedt, T., Lossinsky, A. S., Sheppard, D. C. & Filler, S. G. (2006) Interactions of Aspergillus fumigatus with vascular endothelial cells. Med Mycol, 44 (Suppl 1), S115–7.
Nemerson, Y. (1988) Tissue factor and hemostasis. Blood, 71, 1–8.
Frantz, S., Vincent, K. A., Feron, O. & Kelly, R. A. (2005) Innate immunity and angiogenesis. Circ Res, 96, 15–26.
Asami, Y., Kakeya, H., Okada, G., Toi, M. & Osada, H. (2006) RK-95113, a new angiogenesis inhibitor produced by Aspergillus fumigatus. J Antibiot (Tokyo), 59, 724–8.
Sin, N., Meng, L., Wang, M. Q., Wen, J. J., Bornmann, W. G. & Crews, C. M. (1997) The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci USA, 94, 6099–103.
Schwartz, B., Shoseyov, O., Melnikova, V. O., Mccarty, M., Leslie, M., Roiz, L., Smirnoff, P., Hu, G. F., Lev, D. & Bar-Eli, M. (2007) ACTIBIND, a T2 RNase, competes with angiogenin and inhibits human melanoma growth, angiogenesis, and metastasis. Cancer Res, 67, 5258–66.
Udagawa, T., Yuan, J., Panigrahy, D., Chang, Y. H., Shah, J. & D'amato, R. J. (2000) Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth. J Pharmacol Exp Ther, 294, 421–7.
Jacobson, E. S. (2000) Pathogenic roles for fungal melanins. Clin Microbiol Rev, 13, 708–17.
Jahn, B., Koch, A., Schmidt, A., Wanner, G., Gehringer, H., Bhakdi, S. & Brakhage, A. A. (1997) Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence. Infect Immun, 65, 5110–7.
Langfelder, K., Jahn, B., Gehringer, H., Schmidt, A., Wanner, G. & Brakhage, A. A. (1998) Identification of a polyketide synthase gene (pksP) of Aspergillus fumigatus involved in conidial pigment biosynthesis and virulence. Med Microbiol Immunol, 187, 79–89.
Tsai, H. F., Chang, Y. C., Washburn, R. G., Wheeler, M. H. & Kwon-Chung, K. J. (1998) The developmentally regulated alb1 gene of Aspergillus fumigatus: its role in modulation of conidial morphology and virulence. J Bacteriol, 180, 3031–8.
Jahn, B., Boukhallouk, F., Lotz, J., Langfelder, K., Wanner, G. & Brakhage, A. A. (2000) Interaction of human phagocytes with pigmentless Aspergillus conidia. Infect Immun, 68, 3736–9.
Jahn, B., Langfelder, K., Schneider, U., Schindel, C. & Brakhage, A. A. (2002) PKSP-dependent reduction of phagolysosome fusion and intracellular kill of Aspergillus fumigatus conidia by human monocyte-derived macrophages. Cell Microbiol, 4, 793–803.
Brakhage, A. A. & Liebmann, B. (2005) Aspergillus fumigatus conidial pigment and cAMP signal transduction: significance for virulence. Med Mycol, 43(Suppl 1), S75–82.
Liebmann, B., Gattung, S., Jahn, B. & Brakhage, A. A. (2003) cAMP signaling in Aspergillus fumigatus is involved in the regulation of the virulence gene pksP and in defense against killing by macrophages. Mol Genet Genomics, 269, 420–35.
Liebmann, B., Muller, M., Braun, A. & Brakhage, A. A. (2004) The cyclic AMP-dependent protein kinase a network regulates development and virulence in Aspergillus fumigatus. Infect Immun, 72, 5193–203.
Zhao, W., Panepinto, J. C., Fortwendel, J. R., Fox, L., Oliver, B. G., Askew, D. S. & Rhodes, J. C. (2006) Deletion of the regulatory subunit of protein kinase A in Aspergillus fumigatus alters morphology, sensitivity to oxidative damage, and virulence. Infect Immun, 74, 4865–74.
D'souza, C. A. & Heitman, J. (2001) Conserved cAMP signaling cascades regulate fungal development and virulence. FEMS Microbiol Rev, 25, 349–64.
Holdom, M. D., Lechenne, B., Hay, R. J., Hamilton, A. J. & Monod, M. (2000) Production and characterization of recombinant Aspergillus fumigatus Cu,Zn superoxide dismutase and its recognition by immune human sera. J Clin Microbiol, 38, 558–62.
Calera, J. A., Paris, S., Monod, M., Hamilton, A. J., Debeaupuis, J. P., Diaquin, M., Lopez-Medrano, R., Leal, F. & Latge, J. P. (1997) Cloning and disruption of the antigenic catalase gene of Aspergillus fumigatus. Infect Immun, 65, 4718–24.
Hearn, V. M., Wilson, E. V. & Mackenzie, D. W. (1992) Analysis of Aspergillus fumigatus catalases possessing antigenic activity. J Med Microbiol, 36, 61–7.
Paris, S., Wysong, D., Debeaupuis, J. P., Shibuya, K., Philippe, B., Diamond, R. D. & Latge, J. P. (2003) Catalases of Aspergillus fumigatus. Infect Immun, 71, 3551–62.
Latge, J. P. (1999) Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev, 12, 310–50.
Rhodes, J. C. (2006) Aspergillus fumigatus: growth and virulence. Med Mycol, 44(Suppl 1), S77–81.
Nierman, W. C., May, G., Kim, H. S., Anderson, M. J., Chen, D. & Denning, D. W. (2005) What the Aspergillus genomes have told us. Med Mycol, 43(Suppl 1), S3–5.
Bhabhra, R., Miley, M. D., Mylonakis, E., Boettner, D., Fortwendel, J., Panepinto, J. C., Postow, M., Rhodes, J. C. & Askew, D. S. (2004) Disruption of the Aspergillus fumigatus gene encoding nucleolar protein CgrA impairs thermotolerant growth and reduces virulence. Infect Immun, 72, 4731–40.
Chang, Y. C., Tsai, H. F., Karos, M. & Kwon-Chung, K. J. (2004) THTA, a thermotolerance gene of Aspergillus fumigatus. Fungal Genet Biol, 41, 888–96.
Ibrahim-Granet, O. & D'enfert, C. (1997) The Aspergillus fumigatus mepB gene encodes an 82 kDa intracellular metalloproteinase structurally related to mammalian thimet oligopeptidases. Microbiology, 143(Pt 7), 2247–53.
Monod, M., Paris, S., Sarfati, J., Jaton-Ogay, K., Ave, P. & Latge, J. P. (1993) Virulence of alkaline protease-deficient mutants of Aspergillus fumigatus. FEMS Microbiol Lett, 106, 39–46.
Reichard, U., Monod, M., Odds, F. & Ruchel, R. (1997) Virulence of an aspergillopepsin-deficient mutant of Aspergillus fumigatus and evidence for another aspartic proteinase linked to the fungal cell wall. J Med Vet Mycol, 35, 189–96.
Smith, J. M., Tang, C. M., Van Noorden, S. & Holden, D. W. (1994) Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. Infect Immun, 62, 5247–54.
Tang, C. M., Cohen, J., Krausz, T., Van Noorden, S. & Holden, D. W. (1993) The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect Immun, 61, 1650–6.
Kolattukudy, P. E., Lee, J. D., Rogers, L. M., Zimmerman, P., Ceselski, S., Fox, B., Stein, B. & Copelan, E. A. (1993) Evidence for possible involvement of an elastolytic serine protease in aspergillosis. Infect Immun, 61, 2357–68.
Paris, S., Monod, M., Diaquin, M., Lamy, B., Arruda, L. K., Punt, P. J. & Latge, J. P. (1993) A transformant of Aspergillus fumigatus deficient in the antigenic cytotoxin ASPFI. FEMS Microbiol Lett, 111, 31–6.
Blanco, J. L., Hontecillas, R., Bouza, E., Blanco, I., Pelaez, T., Munoz, P., Perez Molina, J. & Garcia, M. E. (2002) Correlation between the elastase activity index and invasiveness of clinical isolates of Aspergillus fumigatus. J Clin Microbiol, 40, 1811–3.
Rhodes, J. C., Bode, R. B. & Mccuan-Kirsch, C. M. (1988) Elastase production in clinical isolates of Aspergillus. Diagn Microbiol Infect Dis, 10, 165–70.
Kothary, M. H., Chase, T., Jr. & Macmillan, J. D. (1984) Correlation of elastase production by some strains of Aspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice. Infect Immun, 43, 320–5.
Denning, D. W., Ward, P. N., Fenelon, L. E. & Benbow, E. W. (1992) Lack of vessel wall elastolysis in human invasive pulmonary aspergillosis. Infect Immun, 60, 5153–6.
Rasmussen, C., Garen, C., Brining, S., Kincaid, R. L., Means, R. L. & Means, A. R. (1994) The calmodulin-dependent protein phosphatase catalytic subunit (calcineurin A) is an essential gene in Aspergillus nidulans. EMBO J, 13, 2545–52.
Juvvadi, P. R., Arioka, M., Nakajima, H. & Kitamoto, K. (2001) Cloning and sequence analysis of cnaA gene encoding the catalytic subunit of calcineurin from Aspergillus oryzae. FEMS Microbiol Lett, 204, 169–74.
Juvvadi, P. R., Kuroki, Y., Arioka, M., Nakajima, H. & Kitamoto, K. (2003) Functional analysis of the calcineurin-encoding gene cnaA from Aspergillus oryzae: evidence for its putative role in stress adaptation. Arch Microbiol, 179, 416–22.
Steinbach, W. J., Cramer, R. A., Jr., Perfect, B. Z., Asfaw, Y. G., Sauer, T. C., Najvar, L. K., Kirkpatrick, W. R., Patterson, T. F., Benjamin, D. K., Jr., Heitman, J. & Perfect, J. R. (2006) Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus. Eukaryot Cell, 5, 1091–103.
Da Silva Ferreira, M. E., Heinekamp, T., Hartl, A., Brakhage, A. A., Semighini, C. P., Harris, S. D., Savoldi, M., De Gouvea, P. F., De Souza Goldman, M. H. & Goldman, G. H. (2007) Functional characterization of the Aspergillus fumigatus calcineurin. Fungal Genet Biol, 44, 219–30.
Kontoyiannis, D. P., Lewis, R. E., Osherov, N., Albert, N. D. & May, G. S. (2003) Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species. J Antimicrob Chemother, 51, 313–6.
Steinbach, W. J., Reedy, J. L., Cramer, R. A., Jr., Perfect, J. R. & Heitman, J. (2007) Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol, 5, 418–30.
Hersleth, H. P., Ryde, U., Rydberg, P., Gorbitz, C. H. & Andersson, K. K. (2006) Structures of the high-valent metal-ion haem-oxygen intermediates in peroxidases, oxygenases and catalases. J Inorg Biochem, 100, 460–76.
Schrettl, M., Bignell, E., Kragl, C., Joechl, C., Rogers, T., Arst, H. N., Jr., Haynes, K. & Haas, H. (2004) Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence. J Exp Med, 200, 1213–9.
Schrettl, M., Bignell, E., Kragl, C., Sabiha, Y., Loss, O., Eisendle, M., Wallner, A., Arst, H. N., Jr., Haynes, K. & Haas, H. (2007) Distinct roles for intra- and extracellular siderophores during Aspergillus fumigatus infection. PLoS Pathog, 3, 1195–207.
Bartholomew, J. (2008 ) Secondary metabolites of Aspergillus. Last accessed on: 3-9-2008.
Ronning, C. M., Fedorova, N. D., Bowyer, P., Coulson, R., Goldman, G., Kim, H. S., Turner, G., Wortman, J. R., Yu, J., Anderson, M. J., Denning, D. W. & Nierman, W. C. (2005) Genomics of Aspergillus fumigatus. Rev Iberoam Micol, 22, 223–8.
Nierman, W. C. (2008) Genomic insights about secondary metabolite gene clusters/pathways. In 3rd Advances Against Aspergillosis.. Miami, USA.
Bennett, J. W. & Klich, M. (2003) Mycotoxins. Clin Microbiol Rev, 16, 497–516.
Lamy, B., Moutaouakil, M., Latge, J. P. & Davies, J. (1991) Secretion of a potential virulence factor, a fungal ribonucleotoxin, during human aspergillosis infections. Mol Microbiol, 5, 1811–5.
Smith, J. M., Davies, J. E. & Holden, D. W. (1993) Construction and pathogenicity of Aspergillus fumigatus mutants that do not produce the ribotoxin restrictocin. Mol Microbiol, 9, 1071–7.
Cramer, R. A., Jr., Gamcsik, M. P., Brooking, R. M., Najvar, L. K., Kirkpatrick, W. R., Patterson, T. F., Balibar, C. J., Graybill, J. R., Perfect, J. R., Abraham, S. N. & Steinbach, W. J. (2006) Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production. Eukaryot Cell, 5, 972–80.
Murayama, T., Amitani, R., Ikegami, Y., Nawada, R., Lee, W. J. & Kuze, F. (1996) Suppressive effects of Aspergillus fumigatus culture filtrates on human alveolar macrophages and polymorphonuclear leucocytes. Eur Respir J, 9, 293–300.
Mullbacher, A., Waring, P. & Eichner, R. D. (1985) Identification of an agent in cultures of Aspergillus fumigatus displaying anti-phagocytic and immunomodulating activity in vitro. J Gen Microbiol, 131, 1251–8.
Sugui, J. A., Pardo, J., Chang, Y. C., Zarember, K. A., Nardone, G., Galvez, E. M., Mullbacher, A., Gallin, J. I., Simon, M. M. & Kwon-Chung, K. J. (2007) Gliotoxin is a virulence factor of Aspergillus fumigatus: gliP deletion attenuates virulence in mice immunosuppressed with hydrocortisone. Eukaryot Cell, 6, 1562–9.
Tsunawaki, S., Yoshida, L. S., Nishida, S., Kobayashi, T. & Shimoyama, T. (2004) Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase. Infect Immun, 72, 3373–82.
Pahl, H. L., Krauss, B., Schulze-Osthoff, K., Decker, T., Traenckner, E. B., Vogt, M., Myers, C., Parks, T., Warring, P., Muhlbacher, A., Czernilofsky, A. P. & Baeuerle, P. A. (1996) The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB. J Exp Med, 183, 1829–40.
Kweon, Y. O., Paik, Y. H., Schnabl, B., Qian, T., Lemasters, J. J. & Brenner, D. A. (2003) Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. J Hepatol, 39, 38–46.
Suen, Y. K., Fung, K. P., Lee, C. Y. & Kong, S. K. (2001) Gliotoxin induces apoptosis in cultured macrophages via production of reactive oxygen species and cytochrome c release without mitochondrial depolarization. Free Radic Res, 35, 1–10.
Waring, P., Eichner, R. D., Mullbacher, A. & Sjaarda, A. (1988) Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties. J Biol Chem, 263, 18493–9.
Sutton, P., Newcombe, N. R., Waring, P. & Mullbacher, A. (1994) In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi. Infect Immun, 62, 1192–8.
Pardo, J., Urban, C., Galvez, E. M., Ekert, P. G., Muller, U., Kwon-Chung, J., Lobigs, M., Mullbacher, A., Wallich, R., Borner, C. & Simon, M. M. (2006) The mitochondrial protein Bak is pivotal for gliotoxin-induced apoptosis and a critical host factor of Aspergillus fumigatus virulence in mice. J Cell Biol, 174, 509–19.
Lewis, R. E., Wiederhold, N. P., Chi, J., Han, X. Y., Komanduri, K. V., Kontoyiannis, D. P. & Prince, R. A. (2005) Detection of gliotoxin in experimental and human aspergillosis. Infect Immun, 73, 635–7.
Richard, J. L. & Debey, M. C. (1995) Production of gliotoxin during the pathogenic state in turkey poults by Aspergillus fumigatus Fresenius. Mycopathologia, 129, 111–5.
Lewis, R. E., Wiederhold, N. P., Lionakis, M. S., Prince, R. A. & Kontoyiannis, D. P. (2005) Frequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center. J Clin Microbiol, 43, 6120–2.
Dos Santos, V. M., Dorner, J. W. & Carreira, F. (2003) Isolation and toxigenicity of Aspergillus fumigatus from moldy silage. Mycopathologia, 156, 133–8.
Reeves, E. P., Messina, C. G., Doyle, S. & Kavanagh, K. (2004) Correlation between gliotoxin production and virulence of Aspergillus fumigatus in Galleria mellonella. Mycopathologia, 158, 73–9.
Spikes, S., Xu, R., Nguyen, C. K., Chamilos, G., Kontoyiannis, D. P., Jacobson, R. H., Ejzykowicz, D. E., Chiang, L. Y., Filler, S. G. & May, G. S. (2008) Gliotoxin production in Aspergillus fumigatus contributes to host-specific differences in virulence. J Infect Dis, 197, 479–86.
Kupfahl, C., Heinekamp, T., Geginat, G., Ruppert, T., Hartl, A., Hof, H. & Brakhage, A. A. (2006) Deletion of the gliP gene of Aspergillus fumigatus results in loss of gliotoxin production but has no effect on virulence of the fungus in a low-dose mouse infection model. Mol Microbiol, 62, 292–302.
Bok, J. W. & Keller, N. P. (2004) LaeA, a regulator of secondary metabolism in Aspergillus spp. Eukaryot Cell, 3, 527–35.
Bok, J. W., Balajee, S. A., Marr, K. A., Andes, D., Nielsen, K. F., Frisvad, J. C. & Keller, N. P. (2005) LaeA, a regulator of morphogenetic fungal virulence factors. Eukaryot Cell, 4, 1574–82.
Bok, J. W., Chung, D., Balajee, S. A., Marr, K. A., Andes, D., Nielsen, K. F., Frisvad, J. C., Kirby, K. A. & Keller, N. P. (2006) GliZ, a transcriptional regulator of gliotoxin biosynthesis, contributes to Aspergillus fumigatus virulence. Infect Immun, 74, 6761–8.
Balloy, V., Huerre, M., Latge, J. P. & Chignard, M. (2005) Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun, 73, 494–503.
Stergiopoulou, T., Meletiadis, J., Roilides, E., Kleiner, D. E., Schaufele, R., Roden, M., Harrington, S., Dad, L., Segal, B. & Walsh, T. J. (2007) Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. Am J Clin Pathol, 127, 349–55.
Berenguer, J., Allende, M. C., Lee, J. W., Garrett, K., Lyman, C., Ali, N. M., Bacher, J., Pizzo, P. A. & Walsh, T. J. (1995) Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression. Am J Respir Crit Care Med, 152, 1079–86.
Duong, M., Ouellet, N., Simard, M., Bergeron, Y., Olivier, M. & Bergeron, M. G. (1998) Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. J Infect Dis, 178, 1472–82.
Lionakis, M. S. & Kontoyiannis, D. P. (2003) Glucocorticoids and invasive fungal infections. Lancet, 362, 1828–38.
Roilides, E., Uhlig, K., Venzon, D., Pizzo, P. A. & Walsh, T. J. (1993) Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun, 61, 4870–7.
Merkow, L., Pardo, M., Epstein, S. M., Verney, E. & Sidransky, H. (1968) Lysosomal stability during phagocytosis of Aspergillus flavus spores by alveolar macrophages of cortisone-treated mice. Science, 160, 79–81.
Ng, T. T., Robson, G. D. & Denning, D. W. (1994) Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology, 140(Pt 9), 2475–9.
Almawi, W. Y., Beyhum, H. N., Rahme, A. A. & Rieder, M. J. (1996) Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukoc Biol, 60, 563–72.
Seo, K. W., Kim, D. H., Sohn, S. K., Lee, N. Y., Chang, H. H., Kim, S. W., Jeon, S. B., Baek, J. H., Kim, J. G., Suh, J. S. & Lee, K. B. (2005) Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation. Bone Marrow Transplant, 36, 1089–95.
Mezger, M., Steffens, M., Beyer, M., Manger, C., Eberle, J., Toliat, M. R., Wienker, T. F., Ljungman, P., Hebart, H., Dornbusch, H. J., Einsele, H. & Loeffler, J. (2008) Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and influence CXCL10 expression in monocyte-derived dendritic cells. Blood, 111, 534–6.
Bochud, P. Y., Chien, J. W., Janer, M., Marr, K. A. & Boeckh, M. (2006) Donor's toll-like receptor 4 haplotypes increase the incidence of invasive mold infections in hematopoietic stem cell transplant recipients. In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy. California, USA.
Kesh, S., Mensah, N. Y., Peterlongo, P., Jaffe, D., Hsu, K., M, V. D. B., O'reilly, R., Pamer, E., Satagopan, J. & Papanicolaou, G. A. (2005) TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Ann N Y Acad Sci, 1062, 95–103.
Carvalho, A., Pasqualotto, A. C., Pitzurra, L., Romani, L., Denning, D. W. & Rodrigues, F. (2008) Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis. J Infect Dis, 197, 618–21.
Garred, P., Larsen, F., Madsen, H. O. & Koch, C. (2003) Mannose-binding lectin deficiency – revisited. Mol Immunol, 40, 73–84.
Kaur, S., Gupta, V. K., Thiel, S., Sarma, P. U. & Madan, T. (2007) Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis. Clin Exp Immunol, 148, 382–9.
Granell, M., Urbano-Ispizua, A., Suarez, B., Rovira, M., Fernandez-Aviles, F., Martinez, C., Ortega, M., Uriburu, C., Gaya, A., Roncero, J. M., Navarro, A., Carreras, E., Mensa, J., Vives, J., Rozman, C., Montserrat, E. & Lozano, F. (2006) Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation. Exp Hematol, 34, 1435–41.
Crosdale, D. J., Poulton, K. V., Ollier, W. E., Thomson, W. & Denning, D. W. (2001) Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J Infect Dis, 184, 653–6.
Vaid, M., Kaur, S., Sambatakou, H., Madan, T., Denning, D. W. & Sarma, P. U. (2007) Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Clin Chem Lab Med, 45, 183–6.
Kontoyiannis, D. P., Chamilos, G., Lewis, R. E., Giralt, S., Cortes, J., Raad, I. I., Manning, J. T. & Han, X. (2007) Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer, 110, 1303–6.
Marr, K. A., Carter, R. A., Boeckh, M., Martin, P. & Corey, L. (2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood, 100, 4358–66.
Nichols, W. G., Guthrie, K. A., Corey, L. & Boeckh, M. (2004) Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis, 39, 1300–6.
Clancy, C. J. & Nguyen, M. H. (1998) Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease. Chest, 114, 629–34.
Lee, F. E., Daigle, C. C., Urban, M. A., Metlay, L. A., Treanor, J. J. & Trawick, D. R. (2005) Fever and progressive respiratory failure in three elderly family members. Chest, 128, 1863–4, 5–7.
Franke-Ullmann, G., Pfortner, C., Walter, P., Steinmuller, C., Lohmann-Matthes, M. L., Kobzik, L. & Freihorst, J. (1995) Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro. J Immunol, 154, 268–80.
Didierlaurent, A., Goulding, J., Patel, S., Snelgrove, R., Low, L., Bebien, M., Lawrence, T., Van Rijt, L. S., Lambrecht, B. N., Sirard, J. C. & Hussell, T. (2008) Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med, 205, 323–9.
Oh, S. & Eichelberger, M. C. (2000) Polarization of allogeneic T-cell responses by influenza virus-infected dendritic cells. J Virol, 74, 7738–44.
Chang, W. L., Coro, E. S., Rau, F. C., Xiao, Y., Erle, D. J. & Baumgarth, N. (2007) Influenza virus infection causes global respiratory tract B cell response modulation via innate immune signals. J Immunol, 178, 1457–67.
Husni, R. N., Gordon, S. M., Longworth, D. L., Arroliga, A., Stillwell, P. C., Avery, R. K., Maurer, J. R., Mehta, A. & Kirby, T. (1998) Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis, 26, 753–5.
Laursen, A. L., Mogensen, S. C., Andersen, H. M., Andersen, P. L. & Ellermann-Eriksen, S. (2001) The impact of CMV on the respiratory burst of macrophages in response to Pneumocystis carinii. Clin Exp Immunol, 123, 239–46.
Lehner, P. J. & Wilkinson, G. W. (2001) Cytomegalovirus: from evasion to suppression? Nat Immunol, 2, 993–4.
Benjamim, C. F., Hogaboam, C. M., Lukacs, N. W. & Kunkel, S. L. (2003) Septic mice are susceptible to pulmonary aspergillosis. Am J Pathol, 163, 2605–17.
Tsiodras, S., Samonis, G., Boumpas, D. T. & Kontoyiannis, D. P. (2008) Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc, 83, 181–94.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Ben-Ami, R., Kontoyiannis, D.P. (2009). Pathogenesis of Invasive Pulmonary Aspergillosis. In: Comarú Pasqualotto, A. (eds) Aspergillosis: From Diagnosis to Prevention. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2408-4_21
Download citation
DOI: https://doi.org/10.1007/978-90-481-2408-4_21
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-2407-7
Online ISBN: 978-90-481-2408-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)